CHALLENGER LIMITED (CGF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGF

CGF - CHALLENGER LIMITED

Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Challenger Ltd is an Australian financial company that specialises in superannuation and annuities. It claims to be Australia's largest guaranteed income provider. Founded in 1985 it was listed in 2003.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$8.79

28 May
2026

-0.190

OPEN

$9.02

-2.12%

HIGH

$9.02

1,102,642

LOW

$8.73

TARGET
$9.60 9.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CVW . DJW . ENN . GDG . GQG . HMC . HUB . IFT . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
CGF: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx 28.0 66.2 xxx
DPS (cps) xxx 29.5 31.0 xxx
EPS Growth xxx 47.5% 100.0% xxx
DPS Growth xxx 11.3% 5.1% xxx
PE Ratio xxx N/A 13.4 xxx
Dividend Yield xxx N/A 3.5% xxx
Div Pay Ratio(%) xxx 105.4% 46.8% xxx

Dividend yield today if purchased 3 years ago: 4.69%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.33

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - ex-div 15.00c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx28.0
DPS All xxxxxxxxxxxxxxx29.5
Sales/Revenue xxxxxxxxxxxxxxx3,116.1 M
Book Value Per Share xxxxxxxxxxxxxxx563.7
Net Operating Cash Flow xxxxxxxxxxxxxxx399.6 M
Net Profit Margin xxxxxxxxxxxxxxx6.17 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx4.97 %
Return on Invested Capital xxxxxxxxxxxxxxx3.62 %
Return on Assets xxxxxxxxxxxxxxx0.56 %
Return on Equity xxxxxxxxxxxxxxx4.97 %
Return on Total Capital xxxxxxxxxxxxxxx9.99 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx208.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx6,936 M
Long Term Debt xxxxxxxxxxxxxxx1,332 M
Total Debt xxxxxxxxxxxxxxx8,268 M
Goodwill - Gross xxxxxxxxxxxxxxx580 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx650 M
Price To Book Value xxxxxxxxxxxxxxx1.43

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxxxxx0.01 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx802 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx32,809 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

19/05/2026

1

Buy

$9.85

12.06%

Ord Minnett expects Challenger's investor day to focus on the long-term impact of proposed regulatory capital changes.

The broker estimates around $400m of capital could be freed from changes to the illiquidity premium, potentially supporting annuity growth and capital management initiatives.

It's felt adjustments to the asset mix may pressure earnings, limiting the EPS uplift from buybacks.

The key driver of future share price performance, in the analysts' view, will be new distribution agreements capable of accelerating annuity book growth and supporting sustainable EPS expansion.

No change to $9.85 target price and Buy rating.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

26/05/2026

3

Neutral

$8.70

-1.02%

Jarden retains a Neutral rating for Challenger with a $8.70 target price ahead of its annual investor day.

The event is expected to focus on the domestic annuity growth strategy, specifically addressing distribution constraints currently limiting retail sales momentum.

Management is also anticipated to provide further clarity regarding Calix Re, a recently established Bermuda-based reinsurance vehicle expected to provide an offshore growth platform.

The capital deployment framework under revised regulatory standards will be a key topic of interest, with the business holding $442m in distributable surplus capital.

While the forward life margin outlook appears more constructive, the broker remains cautious due to persistent fund management outflows and limited valuation support, leaving earnings estimates unchanged.

FORECAST
Jarden forecasts a full year FY26 dividend of 30.80 cents and EPS of 64.20 cents.
Jarden forecasts a full year FY27 dividend of 32.10 cents and EPS of 69.50 cents.

CGF STOCK CHART